iSpecimen Inc. financials

ISPC CIK 0001558569

Source: EDGAR filings · Built 2026-06-19T01:05:20Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Free Cash Flow -4.24M -8.30M -5.83M -6.03M -10.67M -288.81K
EBITDA -7.25M -10.43M -9.05M -8.98M -4.92M -1.59M
Working Capital 723.28K -2.18M 2.19M 15.39M 30.44M -18.66M
Net Debt -6.61M -1.57M -2.15M -15.12M -24.32M -517.01K
Gross Margin 1.25% 42.93% 51.45% 54.27% 52.86% 56.19%
Operating Margin -465.42% -136.99% -112.50% -97.92% -53.21% -29.40%
Net Margin -543.68% -134.51% -111.80% -98.50% -80.48% -56.84%
Return on Equity (ROE) -339.60% -377.46% -113.95% -50.45% -30.08% 17.05%
Return on Assets (ROA) -110.03% -133.66% -70.16% -41.62% -25.09% -74.92%
Current Ratio 1.12× 0.62× 1.36× 4.60× 13.15× 0.16×
Debt-to-Equity 0.09× 0.09× 0.02× 0.01× 0.11× -0.01×
Cash Conversion Ratio 0.40× 0.66× 0.52× 0.57× 1.19× 0.06×
Accruals Ratio -0.66× -0.45× -0.33× -0.18× 0.05× -0.70×
SBC % of Revenue 1.10% 2.69% 4.63% 6.52% 5.59% 1.13%
CapEx Coverage -9340.55× -261.96× -298.16× -27.00× -4183.69× -676.95×
Free Cash Flow Per Share $-0.92 $-11.67 $-12.89 $-0.68 $-2.49 $-0.31

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 9.93M 10.40M 11.14M 8.18M
Revenues 1.93M 9.29M 9.93M
Cost of Goods and Services Sold 1.90M 5.30M 4.82M 4.76M 5.25M 3.59M
Cost of Revenue 1.71M 5.11M 4.77M
Research and Development Expense 1.49M 1.62M 1.47M 879.24K 319.24K
Operating Income (Loss) -8.98M -12.73M -11.17M -10.19M -5.93M -2.41M
Income Tax Expense (Benefit) 0 0 0 0
Net Income (Loss) Attributable to Parent -10.49M -12.50M -11.10M -10.25M -8.96M -4.65M
Earnings Per Share, Basic $-2.28 $-17.58 $-24.55 $-1.16 $-2.09 $-4.97
Weighted Average Number of Shares Outstanding, Basic 4.60M 710,852 452,067 8.84M 4.29M 936,213
Earnings Per Share, Diluted $-2.28 $-17.58 $-24.55 $-1.16 $-2.09 $-4.97
Weighted Average Number of Shares Outstanding, Diluted 4.60M 710,852 452,067 8.84M 4.29M 936,213

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 6.88M 1.88M 2.34M 15.31M 27.74M 695.91K
Assets, Current 6.95M 3.59M 8.24M 19.68M 32.95M 3.47M
Assets 9.53M 9.35M 15.82M 24.62M 35.72M 6.21M
Long-term Debt 3.42M
Liabilities, Current 6.23M 5.77M 6.05M 4.28M 2.51M 22.14M
Liabilities 6.44M 6.04M 6.08M 4.31M 5.93M 22.31M
Stockholders' Equity Attributable to Parent 3.09M 3.31M 9.74M 20.31M 29.79M -27.28M
Common Stock, Shares, Outstanding 211,965 1.70M 454,169 8.93M 8.73M 936,213

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities -4.24M -8.26M -5.81M -5.82M -10.67M -288.38K
Payments to Acquire Property, Plant, and Equipment 454 31.55K 19.48K 215.50K 2.55K 426
Net Cash Provided by (Used in) Investing Activities -1.00M 1.98M -7.23M -3.19M -1.04M -1.10M
Net Cash Provided by (Used in) Financing Activities 10.24M 5.82M 70.89K -3.42M 38.75M 2.03M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ISPC CIK 0001558569), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RGBPP

REGEN BIOPHARMA, INC.

ATMU

Atmus Filtration Technologies Inc.

HLI

Houlihan Lokey, Inc.